Private Equity

Amid economic headwinds, the M&A advisor thrived by securing over 90 deals and promoting key partners, signaling strong momentum for healthcare sales in 2026.

KKR's landmark purchase of Cheongna Logistics Center, the largest in Korea, signals a massive bet on the nation's booming e-commerce infrastructure.

New Era Energy & Digital faces a major fraud lawsuit from New Mexico over abandoned oil wells, threatening its pivot to a high-tech data center future.

Peruvian financial giant Credicorp is buying Florida's Helm Bank, a strategic move to capture the lucrative cross-border wealth of Latin American clients.

The biopharma investment giant has now acquired 100% of the royalty stream for Roche's blockbuster SMA drug, a strategic move years in the making.

Just months after its IPO, Kandal M Venture is fighting to stay on Nasdaq. We explore the financial woes behind the stock's dramatic fall.

Activist investor Milfam LLC elected its entire slate to Scully Royalty's board at a disputed meeting held outside a locked room, ousting management.

As CooperCompanies heads to the J.P. Morgan conference, all eyes are on CEO Al White's strategic vision for its dual vision and women's health units.

Former CEO Phil Horlock's full departure marks a new chapter for Blue Bird, which is posting record profits and accelerating its lead in electric buses.

A private tender offer values diagnostics firm PathoCare at $1.75B. Can its AI-powered, non-invasive technology justify the price and transform medicine?

XA Investments is launching a new index for credit interval funds, a move set to demystify a booming but opaque market for investors and asset managers.

After resolving a cease trade order, A.I.S. Resources is set to resume trading, putting its diverse gold and lithium projects back in the market spotlight.

After a protracted fight against alleged company intimidation, 24 fuel drivers have joined Teamsters Local 705, seeking better wages and benefits.

Commodity giant Mercuria secures copper and gold from Pucobre's El Espino mine with a $375M financing deal, betting big on Chile and green metals.

After a swift restructuring, Modivcare emerges debt-light and privately owned, poised to aggressively invest in technology and transform supportive care.

Oncodesign Precision Medicine and Navigo Proteins end their radiotheranostics pact, shifting focus to internal programs amid high-stakes R&D challenges.

Beyond the grid, Xcel Energy invested over $14M and nearly 60,000 volunteer hours, strategically fueling local economies and its own green future.

A strategic acquisition, backed by Argonne Capital, sets the stage for major expansion in Texas's booming specialized lighting and holiday décor market.

The Danish firm scraps its 2025 revenue forecast, accepting a larger loss in a bold move to secure more lucrative future deals for its key drug candidates.

Formerly Nature Wood Group, the forestry firm reports a surprise profit despite falling revenue after a complete change in ownership and leadership.